Construction News

Sun June 13 2021

Related Information

Aecom expands role on $2.2bn Istanbul scheme

5 Sep 12 Aecom has been appointed project manager on Phase 1a of the US$2.2bn (£1.38bn) Bio Istanbul biomedical science park.

The development will become Turkey’s first dedicated biomedical science park, advanced children’s hospital and sustainable residential community.

Aecom will project manage the construction of three distinct campuses – the Istanbul Children’s Hospital, an R&D innovation campus and the community’s first 150 residential units. The appointment comes a year after Aecom company Davis Langdon was appointed cost and programme manager on the project.

Phase 1a includes the construction of the hospital designed by Gmur Architekten of Switzerland, the R&D campus designed by Rafael de La-Hoz of Madrid and the residential units designed by Tabanlioglu of Istanbul and Saunders Architecture of Norway.

Concept design is now complete for the three campuses and Aecom will manage the project through completion of construction, while supporting the client team in the development of the wider site infrastructure planning and delivery.

Related Information

Bio Istanbul is a joint venture between healthcare infrastructure company Bio City Development Company; EPP, an affiliate of the Housing Development Administration of Turkey; and the Turkish Ministry of Urbanization & Environment. The facilities’ occupiers will include pharmaceutical, medical technology and biomedical informatics companies.

“Our goal is to significantly expand Turkey’s knowledge-based economy while at the same time surpassing the current de facto standards of Turkish private development,” said Bio Istanbul chairman and CEO Tobias Levey.  “We are relying on Aecom to ensure that our ambition for quality in construction is delivered on time and on budget.”

Aecom managing director for CIS and Turkey David Whitehouse said that Bio Istanbul has the potential to dramatically improve the level of medical care for the people of Turkey while also positioning the country to become the leading centre for pharmaceutical and advanced biomedical research for southeastern Europe and the Middle East. “Having worked with Bio City Development Company from the outset of this important project, it is exciting for everyone at Aecom that our role in seeing it successfully delivered has been expanded,” he said.

When completed, Bio Istanbul will accommodate 15,000 residents and a further 20,000 working commuters. It will be the first large-scale community in Turkey built to meet internationally certified sustainability standards. It will incorporate smart city infrastructure initiatives to ensure efficient use of energy and facilities, an integrated transport network with an intra-site public tramway and a comprehensive site security system.

Got a story? Email news@theconstructionindex.co.uk

MPU

Click here to view more construction news »